Cargando…
Systematic review of pharmacological treatments in fragile X syndrome
BACKGROUND: Fragile X syndrome (FXS) is considered the most common cause of inherited mental retardation. Affected people have mental impairment that can include Attention Deficit and/or Hyperactivity Disorder (ADHD), autism disorder, and speech and behavioural disorders. Several pharmacological int...
Autores principales: | Rueda, Jose-Ramon, Ballesteros, Javier, Tejada, Maria-Isabel |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770029/ https://www.ncbi.nlm.nih.gov/pubmed/19822023 http://dx.doi.org/10.1186/1471-2377-9-53 |
Ejemplares similares
-
Emerging pharmacologic treatment options for fragile X syndrome
por: Schaefer, Tori L, et al.
Publicado: (2015) -
Neurodevelopment and early pharmacological interventions in Fragile X Syndrome
por: Milla, Luis A., et al.
Publicado: (2023) -
Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes
por: Wang, Hansen, et al.
Publicado: (2015) -
Fragile X syndrome and fragile X-associated disorders
por: Rajaratnam, Akash, et al.
Publicado: (2017) -
Fragile X Syndrome
por: Saldarriaga, Wilmar, et al.
Publicado: (2014)